MCC 2022 Holiday Letter

Dear friends of Merkel cell carcinoma Merkel cell carcinoma A skin cancer composed of cells that look microscopically similar to normal Merkel cells present in the skin. MCC was first described in 1972 and only in the 1990s was the CK20 antibody developed to make it easily identifiable by pathologists. Many doctors and patients are not aware of this cancer because of its recent description and relative rarity (~2,000 cases/year in the US--roughly 30 times less common than melanoma). About 40% of patients treated for MCC will experience a recurrence, making it far more aggressive than most other types of skin cancer, including melanoma. research,

As we enter this season of gratitude and reflection, I would like to thank you for your partnership. I am pleased to share our annual holiday letter, which describes some of the progress that you have made possible this year. If you would like to continue supporting this work, you may do so via our online giving page. Your support is vital to catalyzing discoveries that will continue to impact patients and their families, today and in the future.

Please click the button below to download a PDF of this year’s updates.

2022 Holiday Letter


Best wishes for a happy and healthy 2023.


Paul Nghiem